Please login to the form below

Not currently logged in
Email:
Password:

Gilead to acquire Arresto Bioscences

Gilead will acquire Arresto Biosciences for $225m plus potential future payments based on sales levels

Gilead will acquire Arresto Biosciences for $225m plus potential future payments based on sales levels.

Arresto Viosciences is a privately held development-stage technology company focused on medicines to treat fibrotic diseases and cancer. The agreement will provide Gilead with access to Arresto's lead product, AB0024, a monoclonal antibody in phase I trials for the treatment of cancer and idiopathic pulmonary fibrosis. Gilead has a treatment called ambristentan for the same lung disease.

Norbert W Bischofberger, Gilead's executive vice president and chief scientific officer said: "Arresto's research and development expertise is well aligned with Gilead's areas of focus, including our ongoing clinical programme for ambrisentan in IPF. We look forward to working with the team from Arresto to advance the development of novel therapies for serious fibrotic diseases and explore their potential for the treatment of tumours."

Gilead anticipates the deal will close in the first quarter of 2011, subject to satisfaction of certain closing conditions and plans to finance the cash acquisition.

21st December 2010

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
HAVAS LYNX

Welcome to HAVAS LYNX, a leading global healthcare communications group....

Latest intelligence

NEW EU DATA PROTECTION REGULATION POISED TO CHANGE DATA PRIVACY LANDSCAPE
NEW EU DATA PROTECTION REGULATION POISED TO CHANGE DATA PRIVACY LANDSCAPE The bold digital clock featured on the EUGDPR (EU General Data Protection Regulation)1 website indicates – to the second...
Health knowledge: Why is it so important?
Health knowledge plays an important role in population health, but by itself is rarely enough to prompt a change in the behaviours that cause the risks....
Personas: a top tool for personalising pharma marketing campaigns
Healthcare customers are calling for greater personalisation in care from providers. Here, we explain why personas are the top tool for ensuring your brand meets this need efficiently and effectively....

Infographics